Antibody-Based Therapies in Multiple Myeloma

The unmet need for improved multiple myeloma (MM) therapy has stimulated clinical development of monoclonal antibodies (mAbs) targeting either MM cells or cells of the bone marrow (BM) microenvironment. In contrast to small-molecule inhibitors, therapeutic mAbs present the potential to specifically...

Descripción completa

Detalles Bibliográficos
Autores principales: Tai, Yu-Tzu, Anderson, Kenneth C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2011
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3200112/
https://www.ncbi.nlm.nih.gov/pubmed/22046572
http://dx.doi.org/10.1155/2011/924058

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3200112/
https://www.ncbi.nlm.nih.gov/pubmed/22046572
http://dx.doi.org/10.1155/2011/924058

Ejemplares similares